Universitätsmedizin Berlin has found that a single dose of the Imvanex vaccine provides protection against mpox with 84% ...

One dose of the Jynneos vaccine was 58% effective against mpox infection overall and 84% in people without HIV, but only 35% ...

which can be challenging for some individuals to maintain. But a study released in The Lancet now indicates that it might be ...

In his first term, President Donald Trump launched a bold and successful initiative against HIV. This time around, the ...

Yearly lenacapavir injection for HIV prevention shows safety and long-lasting effects, according to clinical trial results.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.

Increasing HPV vaccination rates could help decrease the number of cancer cases “attributable to HIV,” according to data from a study presented at the Conference on Retroviruses and Opportunistic ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...

“The Scottish Medicines Consortium has finally approved two monthly PrEP injections for use in Scotland, but we are waiting for Nice approval for use in England. “Thanks to rapid HIV ...